The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Come March, Medicare patients who meet income eligibility, which is at or below 300% of the Federal Poverty Level, and are ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

JVP will be paying twice the amount it received for a $338,817 second-draw loan under the Paycheck Protection Act Program.

The researchers believe their findings will have broad application to autoimmune diseases ... In healthy individuals, mRNA COVID-19 vaccines create neutralizing antibodies and establish immune ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...